Thursday, December 14, 2017

Dr. Scott Sherman M.D. to Head Up CannaVision (OTC: $SVSN) Medical Cannabis and Pain Management Clinic in Sunrise, Florida

Dr. Scott Sherman M.D. to Head Up CannaVision (OTC: $SVSN) Medical Cannabis and Pain Management Clinic in Sunrise, Florida



LAS VEGAS, NV - December 14, 2017 (Investorideas.com Newswire) StereoVision Entertainment, Inc. (OTC PINK: SVSN), a publicly traded Nevada Corporation announced today that their majority-owned medical cannabis/industrial hemp subsidiary CannaVision has signed Dr. Scott Sherman M.D. to head up a CannaVision Medical Cannabis and Pain Management Clinic in Sunrise, Florida.


"We're happy to welcome Dr. Sherman to CannaVision's medical staff," said CannaVision's Chairman and Chief Medical Officer Dr. Jay Ellenby M.D. "Our primary focus is treating vets and cancer patients and I look forward to working with Dr. Sherman. The Miami medical cannabis clinic market has quickly become overcrowded so we're moving our Coral Gables clinic operations to Sunrise. With Sunrise centered amidst a number of VA medical facilities and cancer treatment centers this area best serves our purpose."

StereoVision Entertainment Inc. http://stereovision.com Headquartered in Las Vegas, Nevada StereoVision is a publicly traded Nevada corporation (OTC:SVSN) focused on creating, acquiring, and producing multimedia content with its media subsidiaries, the wholly owned 9 time Emmy Award-winning production company REZN8, http://rezn8.com, the majority-owned family entertainment company, Inspirational Vision Media, Inc. http://ivmi.biz, and the majority-owned medical cannabis clinic and industrial hemp Florida C corporation MediCannaVision Inc., dba CannaVision. http://cannavisionclinics.com

Safe Harbor Statement: Except for historical information certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and those statements are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company cautions that these forward-looking statements are qualified by other factors. The Company undertakes no obligation to publicly update any statements in this release.

Contact:
Steve Previch
305-972-1030
Steven@cannavisionclinics.com

Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory. http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.